Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mutsuo Yamaya

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 4, 2016
[Effects of mucolytic agents and macrolides in the treatment of COPD]Mutsuo Yamaya
The Japanese Journal of Antibiotics|March 29, 2012
[Effects of macrolides in preventing influenza and airway inflammation]Mutsuo Yamaya
Pulmonary Medicine|September 12, 2012
Virus infection-induced bronchial asthma exacerbationMutsuo Yamaya
Geriatrics & Gerontology International|March 28, 2012
Chronic obstructive pulmonary disease and severe pneumoniaMutsuo Yamaya
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 20, 2003
[Pneumonia of the aged]Mutsuo Yamaya
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|February 11, 2012
[Prevention and management of geriatric syndrome; aspiration and pneumonia]Mutsuo Yamaya
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 12, 2011
[Pharmacologic treatments of COPD depending on disease severity]Mutsuo Yamaya
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 21, 2005
[Pneumonia among the aged]Mutsuo Yamaya
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|April 3, 2002
[Etiology, pathogenesis and management of senile inflammatory pulmonary diseases]Mutsuo Yamaya, Hidetada Sasaki
The Tohoku Journal of Experimental Medicine|September 9, 2015
A Synthetic Serine Protease Inhibitor, Nafamostat Mesilate, Is a Drug Potentially Applicable to the Treatment of Ebola Virus DiseaseHidekazu Nishimura, Mutsuo Yamaya
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 4, 2016
[Effects of mucolytic agents and macrolides in the treatment of COPD]Mutsuo Yamaya
The Japanese Journal of Antibiotics|March 29, 2012
[Effects of macrolides in preventing influenza and airway inflammation]Mutsuo Yamaya
Pulmonary Medicine|September 12, 2012
Virus infection-induced bronchial asthma exacerbationMutsuo Yamaya
Geriatrics & Gerontology International|March 28, 2012
Chronic obstructive pulmonary disease and severe pneumoniaMutsuo Yamaya
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 20, 2003
[Pneumonia of the aged]Mutsuo Yamaya
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|February 11, 2012
[Prevention and management of geriatric syndrome; aspiration and pneumonia]Mutsuo Yamaya
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 12, 2011
[Pharmacologic treatments of COPD depending on disease severity]Mutsuo Yamaya
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 21, 2005
[Pneumonia among the aged]Mutsuo Yamaya
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|April 3, 2002
[Etiology, pathogenesis and management of senile inflammatory pulmonary diseases]Mutsuo Yamaya, Hidetada Sasaki
The Tohoku Journal of Experimental Medicine|September 9, 2015
A Synthetic Serine Protease Inhibitor, Nafamostat Mesilate, Is a Drug Potentially Applicable to the Treatment of Ebola Virus DiseaseHidekazu Nishimura, Mutsuo Yamaya
Pageof 14